EU health ministers have reached a consensus on the Biotech Act I directive, aimed at modernizing regulations related to genetically modified organisms and organ processing. The directive seeks to enhance innovation while ensuring safety and ethical standards in biotechnology. As discussions with the European Parliament are set to begin, the focus will be on balancing innovation with safety oversight.